Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism.

about

Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism.

Item

http://www.wikidata.org/entity/Q45388175

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Synthesis and HIV-1 RT inhibit ...... petitive inhibition mechanism.

@en

Synthesis and HIV-1 RT inhibitory action of novel

@nl

type

Item

label

Synthesis and HIV-1 RT inhibit ...... petitive inhibition mechanism.

@en

Synthesis and HIV-1 RT inhibitory action of novel

@nl

prefLabel

Synthesis and HIV-1 RT inhibit ...... petitive inhibition mechanism.

@en

Synthesis and HIV-1 RT inhibitory action of novel

@nl

P1476

Synthesis and HIV-1 RT inhibit ...... petitive inhibition mechanism.

@en

P2093

Athina Geronikaki

http://www.w3.org/2001/XMLSchema#string

Eleni Pitta

http://www.w3.org/2001/XMLSchema#string

Erik V Van der Eycken

http://www.w3.org/2001/XMLSchema#string

Phaedra Eleftheriou

http://www.w3.org/2001/XMLSchema#string

Sofiko Surmava

http://www.w3.org/2001/XMLSchema#string

Vaibhav P Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1

The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design

Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor

Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance

Automated docking of flexible ligands: applications of AutoDock

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication

A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine

P304

113-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14756366.2011.636362

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22380777

http://www.w3.org/2001/XMLSchema#string